Nephrology -- Dialysis -- Transplantation
Seiten
2010
Nova Science Publishers Inc (Verlag)
978-1-60741-736-1 (ISBN)
Nova Science Publishers Inc (Verlag)
978-1-60741-736-1 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
Nephrology deals with the study of the function and diseases of the kidney. Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the cause of renal failure in 5-10 per cent of the patients in dialysis or transplantation. This book discusses the several conditions which are associated with the rate of progression.
Nephrology deals with the study of the function and diseases of the kidney. Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the cause of renal failure in 5-10% of the patients in dialysis or transplantation. This book discusses the several conditions which are associated with the rate of progression. Peritoneal dialysis (PD), which has been widely used as one of the major renal replacement therapies for end-stage renal disease (ESRD) patients is also explored in this book. Furthermore, the important role of PAI-1 and the value of therapeutic approaches targeting PAI-1 in progressive renal fibrosis is also examined. Because renal interstitial fibrosis occurs in virtually all the progressive renal diseases leading to end-stage renal failure, controlling it would be a reasonable therapeutic strategy. Other chapters in this book include a review of therapeutic plasma exchanges (TPE), the potential mechanisms that may regulate the effect of macrophages upon renal interstitial fibrosis and the pathophysiological implications of inflammation in the pathogenesis of diabetic nephropathy.
Nephrology deals with the study of the function and diseases of the kidney. Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the cause of renal failure in 5-10% of the patients in dialysis or transplantation. This book discusses the several conditions which are associated with the rate of progression. Peritoneal dialysis (PD), which has been widely used as one of the major renal replacement therapies for end-stage renal disease (ESRD) patients is also explored in this book. Furthermore, the important role of PAI-1 and the value of therapeutic approaches targeting PAI-1 in progressive renal fibrosis is also examined. Because renal interstitial fibrosis occurs in virtually all the progressive renal diseases leading to end-stage renal failure, controlling it would be a reasonable therapeutic strategy. Other chapters in this book include a review of therapeutic plasma exchanges (TPE), the potential mechanisms that may regulate the effect of macrophages upon renal interstitial fibrosis and the pathophysiological implications of inflammation in the pathogenesis of diabetic nephropathy.
Preface; New Pathogenic Perspectives in Diabetic Renal Disease: Diabetic Nephropathy as an Inflammatory Condition; Indexing Glomerular Filtration Rate for Body Surface Area: Myth & Reality; Advances in the Peritoneal Dialysis & Future Prospects; Role of Plasminogen Activator Inhibitor-1 in the Development of Renal Interstitial Fibrosis; Pathogenesis & Resolution Mechanisms of Acute Poststreptococcal Glomerulonephritis; Progression of Autossomal Dominant Polycystic Kidney Disease: A Follow-up Study of a Large Cohort in a Single Center; Genetics in Clinical Nephrology; Plasma Exchanges Prescription for Nephrologists; The Role of Macrophages in Obstructive Nephropathy; Whence Forth After the GWAS Wave for Diabetic Nephropathy?; Index.
| Erscheint lt. Verlag | 21.5.2010 |
|---|---|
| Zusatzinfo | Illustrations, unspecified |
| Verlagsort | New York |
| Sprache | englisch |
| Maße | 260 x 180 mm |
| Gewicht | 590 g |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Nephrologie |
| ISBN-10 | 1-60741-736-7 / 1607417367 |
| ISBN-13 | 978-1-60741-736-1 / 9781607417361 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
